GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
$17.07
-0.120 (-0.698%)
At Close: Apr 18, 2024
Forecast Earnings Fundamentals Insider Trading Signals Historical Prices Predictions News Profile

Range Low Price High Price Comment
30 days $16.60 $19.00 Thursday, 18th Apr 2024 ACAD stock ended at $17.07. This is 0.698% less than the trading day before Wednesday, 17th Apr 2024. During the day the stock fluctuated 1.97% from a day low at $17.01 to a day high of $17.35.
90 days $16.60 $29.29
52 weeks $16.60 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
2020-10-23 $42.37 $43.33 $42.16 $43.17 920 947
2020-10-22 $41.02 $42.47 $41.02 $42.23 492 170
2020-10-21 $41.34 $41.59 $40.61 $41.04 527 890
2020-10-20 $41.49 $41.98 $40.38 $41.21 1 028 979
2020-10-19 $42.93 $43.47 $41.40 $41.49 745 605
2020-10-16 $42.56 $44.28 $42.50 $42.61 1 493 656
2020-10-15 $42.45 $43.19 $41.92 $42.71 697 909
2020-10-14 $43.79 $43.81 $42.90 $42.92 534 096
2020-10-13 $43.25 $43.65 $42.88 $43.26 413 239
2020-10-12 $43.19 $43.57 $42.57 $43.12 738 268
2020-10-09 $43.17 $43.30 $42.41 $42.73 547 234
2020-10-08 $43.21 $43.21 $42.16 $43.18 630 823
2020-10-07 $41.95 $43.15 $41.93 $42.89 718 476
2020-10-06 $42.20 $42.70 $41.48 $41.68 630 478
2020-10-05 $41.82 $42.40 $41.54 $42.14 1 161 965
2020-10-02 $41.39 $42.22 $40.87 $41.36 1 044 974
2020-10-01 $41.25 $42.36 $41.24 $42.14 724 459
2020-09-30 $41.11 $41.64 $40.56 $41.25 883 798
2020-09-29 $40.10 $40.93 $39.88 $40.41 600 115
2020-09-28 $40.58 $40.67 $39.67 $40.23 631 451
2020-09-25 $38.73 $40.51 $38.65 $40.18 821 540
2020-09-24 $40.04 $40.11 $37.56 $38.61 2 242 979
2020-09-23 $41.00 $41.40 $40.35 $40.45 807 136
2020-09-22 $41.53 $41.53 $39.57 $40.97 928 128
2020-09-21 $41.79 $42.02 $40.58 $41.32 1 158 104
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Golden Star

Ticker Date Change Price
FTSL Apr 16 0.304% $46.08
FCN Apr 16 0.0096% $207.62
ELV Apr 16 3.59% $506.97
ITCI Apr 05 5.20% $68.44
AKR Apr 05 1.33% $16.53
SARK Mar 28 16.44% $26.88
ARCC Mar 25 1.49% $20.12
STT Mar 19 0.578% $72.62
BK Mar 19 0.0181% $55.24
LNC Mar 18 0.221% $27.17
Unlock

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT